Breathonix, a spin, Oct. 22 -- off company from the National University of Singapore (NUS), has developed an easy-to-use breath test to detect COVID-19 within a minute. This game-changing technology, which is believed to be the first in Asia, achieved more than 90 per cent accuracy in a Singapore-based pilot clinical trial that involved 180 patients.

"Our breath test is easy to administer, and it does not require specially-trained staff or laboratory processing. Results are generated in real-time, making it an attractive solution for mass screening, especially in areas with high human traffic. We believe our breath analysis platform shows promise in changing the tides of this pandemic," said Dr Jia, Chief Executive Officer of Breathonix....